Lymphatic Malformations Clinical Trial
Official title:
Pilot Clinical Trial to Estimate the Safety and Efficacy of Selenium in the Treatment of Complicated Lymphatic Malformations in Adolescents and Young Adults
The investigators propose a pilot trial to obtain preliminary information regarding the
safety and response rate of patients with symptomatic lymphatic malformations treated with
oral Selenium. Information obtained in this pilot trial will be used to plan future phase 2
clinical trials.
Hypotheses:
- Selenium will be safe and efficacious in the treatment of adolescents and young adults
with symptomatic lymphatic malformations
- Disease response will correlate with serum levels of selenium and blood levels of
antioxidants essential to selenium metabolism.
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03427619 -
OK432 (Picibanil) in the Treatment of Lymphatic Malformations
|
Phase 2 | |
| Recruiting |
NCT05948943 -
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
|
Phase 2/Phase 3 | |
| Completed |
NCT02335242 -
Sildenafil for the Treatment of Lymphatic Malformations
|
Phase 2 | |
| Completed |
NCT00577213 -
Diagnosis of Hemangiomas and Vascular Malformations
|
N/A | |
| Completed |
NCT00866827 -
Airway Vascular Lesions
|
||
| Completed |
NCT00010452 -
Study of Picibanil (OK432) Sclerotherapy in Children With Macrocystic Lymphatic Malformations
|
Phase 2/Phase 3 |